1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,460 | 1,490 | 16.10. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.09. | Intelligent Bio Solutions updates FDA 510(k) timeline for drug test | 3 | Investing.com | ||
| 26.09. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance | 191 | GlobeNewswire (Europe) | The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in the second half of 2026 NEW YORK, Sept. 26... ► Artikel lesen | |
| 25.09. | Intelligent Bio Solutions verlängert Laufzeit von Optionsscheinen der Serie H-1 bis März 2026 | 9 | Investing.com Deutsch | ||
| INTELLIGENT BIO SOLUTIONS Aktie jetzt für 0€ handeln | |||||
| 25.09. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 17.09. | Intelligent Bio Solutions faces FDA request for new 510(k) submission | 4 | Investing.com | ||
| 17.09. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 17.09. | Intelligent Bio Solutions: FDA fordert neuen 510(k)-Antrag für Drogenscreening-System | 4 | Investing.com Deutsch | ||
| 17.09. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System | 151 | GlobeNewswire (Europe) | NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| 19.08. | Intelligent Bio Solutions rise on record cartridge sales | 4 | Seeking Alpha | ||
| 19.08. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July | 156 | GlobeNewswire (Europe) | NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| 15.08. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 6 | SEC Filings | ||
| 15.08. | Intelligent Bio Solutions GAAP EPS of -$2.00, revenue of $3.05M | 4 | Seeking Alpha | ||
| 15.08. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies | 214 | GlobeNewswire (Europe) | Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue... ► Artikel lesen | |
| 15.08. | INTELLIGENT BIO SOLUTIONS INC. - 10-K, Annual Report | 2 | SEC Filings | ||
| 07.08. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum | 162 | GlobeNewswire (Europe) | Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry... ► Artikel lesen | |
| 07.08. | EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4 | 3 | Benzinga.com | ||
| 06.08. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.08. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch | 263 | GlobeNewswire (Europe) | NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| 30.07. | London transport operator selects INBS for drug screening system | 3 | Investing.com | ||
| 30.07. | Intelligent Bio Solutions secures drug testing tender with a London transport operator | 4 | Seeking Alpha |
1 2 3 4 Weiter >>
61 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 17,180 | +1,00 % | Eckert & Ziegler-Aktie sorgt für Aufsehen - was jetzt durchsickert, könnte den Kurs verändern! | ||
| DRAEGERWERK | 75,70 | +12,82 % | EQS-Adhoc: Drägerwerk AG & Co. KGaA: Vorläufige Zahlen Q3 2025: Deutlicher Umsatz- und Ergebnisanstieg - obere Hälfte der Prognosespanne erwartet | EQS-Ad-hoc: Drägerwerk AG & Co. KGaA / Schlagwort(e): Vorläufiges Ergebnis/Prognose
Drägerwerk AG & Co. KGaA: Vorläufige Zahlen Q3 2025: Deutlicher Umsatz- und Ergebnisanstieg - obere Hälfte... ► Artikel lesen | |
| TELADOC HEALTH | 7,620 | -1,31 % | Teladoc Health, Inc.: Teladoc Health to Announce Third Quarter 2025 Financial Results | ||
| ROKU | 81,45 | -0,12 % | Access Advance HEVC and Video Distribution Pool Patent Owners Bring Streaming and Device Patent Infringement Suit Against Roku in Brazil | BOSTON, MA / ACCESS Newswire / October 14, 2025 / Access Advance LLC today announced that certain patent owners in the HEVC Advance and Video Distribution Patent Pools have filed patent infringement... ► Artikel lesen | |
| HIMS & HERS HEALTH | 50,56 | -0,12 % | S&P 500, Nasdaq Slide On Bad Loan Fears; Broadcom, Hims, Oracle Are Top Stocks To Watch | ||
| BICO GROUP | 2,132 | -0,47 % | BICO Group AB: Maria Rankka appointed Board Chair of BICO Group AB | The Board of Directors has with immediate effect among its members elected Maria Rankka to serve as Board Chair of BICO Group AB, until a new chair has been elected by the shareholders' meeting. Maria... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,115 | +9,52 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
| GERATHERM MEDICAL | 3,860 | +2,39 % | Geratherm Medical AG: Starkes Wachstum im ersten Halbjahr und operatives Break-even; KAUFEN bestätigt. | Geratherm verzeichnete im ersten Halbjahr 2025 ein starkes Wachstum: Die vergleichbaren Umsätze stiegen um 13,2 % gegenüber dem Vorjahr und sequenziell um 15,4 %. Getrieben wurde dieses Wachstum von... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB erweitert Investitionen in Italien mit Eröffnung eines neuen Vorzeige-Medizinzentrums in Florenz | EQS-News: SYNLAB
/ Schlagwort(e): Expansion
SYNLAB erweitert Investitionen in Italien mit Eröffnung eines neuen Vorzeige-Medizinzentrums in Florenz
09.10.2025 / 15:00 CET/CEST
Für... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 112,50 | +1,26 % | Mizuho senkt Kursziel für Align Technology wegen Sorgen um Konsumklima | ||
| NUGEN MEDICAL DEVICES | 0,032 | +1,90 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| PLUS THERAPEUTICS | 0,610 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide Cerebrospinal Fluid Assay for Metastatic CNS Cancer | HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), announced today that it has signed... ► Artikel lesen | |
| HEALWELL AI | 0,840 | -1,35 % | WELL Health and HEALWELL AI are buys, Stifel says | ||
| ATOSSA THERAPEUTICS | 0,899 | +2,04 % | Atossa Therapeutics Inc: Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness | 25+ year life-sciences finance leader brings revenue-forecasting rigor, public-company controls, and capital-markets experience as Atossa prepares for commercial... ► Artikel lesen | |
| SPINEWAY | 0,190 | -3,16 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen |
Das Unternehmen INTELLIGENT BIO SOLUTIONS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,475 Euro und damit -100,00 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INTELLIGENT BIO SOLUTIONS INC finden Sie auf Wallstreet Online.